Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer [Phase 4]
This update describes a Phase 4 pharmacokinetic study of a skeletal muscle area-based paclitaxel infusion in cancer patients and is currentl…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 trial results update evaluating estradiol for ER beta–positive, triple-negative breast cancer in locally advanced or metastatic dise…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 Study
This clinical trial evaluates how genetic risk estimates may influence decision making in women at high risk of breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging
This completed pilot observational study at the University of Michigan evaluated whether endocrine therapy for breast cancer has effects on …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
The MOMENTUM study is evaluating radiation therapy using an MR-Linac across multiple cancer types and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu [Phase 2]
A Phase 2 clinical trial at the University of Utah is evaluating a structured exercise program to improve zest and energy in patients with m…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer [NA]
This clinical trial update covers sentinel lymph node biopsy after neoadjuvant chemotherapy in locally advanced breast cancer. The study is …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: The Person-centered Evolution of Radiotherapy Services in Ontario Study [NA]
This entry reports a clinical trial titled 'The Person-centered Evolution of Radiotherapy Services in Ontario Study' sponsored by University…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib [Phase 2]
A Phase 2 pragmatic trial in hormone receptor-positive, HER2-negative early breast cancer is testing optimized neoadjuvant therapy and poten…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility [NA]
The trial completed a pilot evaluation of a web-based decision aid to support fertility preservation decisions in young women with breast ca…
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: IL-1 Inhibition in Early TNBC [Phase 2]
A Phase 2 trial evaluating IL-1 inhibition in early-stage triple-negative breast cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) [Phase 3]
This clinical trial update describes a Phase 3 study (DYNASTY-Breast02) comparing DB-1303/BNT323 against investigator's choice chemotherapy …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating hypofractionated partial breast irradiation for early-stage breast cancer has been suspended.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population [Phase 2]
This is a Phase 2 proof-of-concept clinical trial assessing treatments' efficacy in HR-positive/HER2-negative early breast cancer by monitor…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is evaluating radiation therapy before surgery for hormone receptor–positive, HER2-negative breast cancer; the stud…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer [Phase 2]
This Phase 2 clinical trial is evaluating olaparib in combination with cediranib or AZD6738 for advanced or metastatic germline BRCA-mutated…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients [Phase 2]
A Phase 2 clinical trial comparing solifenacin to clonidine to reduce hot flashes in breast cancer patients, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery [NA]
An update on a clinical trial evaluating hypnosedation to relax patients undergoing breast cancer surgery.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer [NA]
A clinical trial evaluating exercise during chemotherapy for older women with stage I-III breast cancer; the study is currently active but n…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer [NA]
The study evaluating circulating tumor DNA–based minimal residual disease detection in early-stage breast cancer is currently suspended.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction [NA]
This clinical trial update describes a patient-specific decision aid system to support shared decision making about breast reconstruction in…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care [NA]
This clinical trial update describes implementing pharmacogenomic testing in oncology care to guide treatment decisions, with focus on gastr…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer [Phase 1]
This update describes a Phase 1 clinical trial evaluating a TRAIL-R2 and HER2 bi-specific CAR T cell therapy for metastatic breast cancer; t…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
A study led by Tempus AI is evaluating minimal residual disease in breast cancer by longitudinal ctDNA profiling to track disease status acr…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy [Phase 3]
Phase 3 randomized trial evaluating adjuvant atezolizumab or placebo with trastuzumab emtansine in HER2-positive breast cancer at high risk …